Trial Profile
Effect of Spiriva(R) 18 Microgram on Health-related Quality of Life and Physical Functioning in Patients With COPD and Proven Hyperinflation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Jun 2014
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 27 Jun 2014 New trial record